About Argos Therapeutics
Argos Therapeutics is a company based in Durham (United States) founded in 1997 was acquired by Genexine in February 2019. It operates as a Commission-Based. Argos Therapeutics has raised $169.65 million across 15 funding rounds from investors including SVB, ABN AMRO and Edelman Financial Engines. The company has 40 employees as of December 31, 2022. Argos Therapeutics offers products and services including Tai Xiu Online. Argos Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Durham, United States
- Employees 40 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$1.9 M (USD)101as on Dec 31, 2017
-
Net Profit
-$40.58 M (USD)23as on Dec 31, 2017
-
EBITDA
-$62.46 M (USD)-19as on Dec 31, 2017
-
Total Equity Funding
$169.65 M (USD)
in 15 rounds
-
Latest Funding Round
$6 M (USD), Post-IPO
Jun 16, 2017
-
Investors
SVB
& 29 more
-
Employee Count
40
as on Dec 31, 2022
-
Acquired by
Genexine
(Feb 13, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Argos Therapeutics
Argos Therapeutics offers a comprehensive portfolio of products and services, including Tai Xiu Online.
Online Tai Xiu game platform is provided for users.
People of Argos Therapeutics
Unlock access to complete
Funding Insights of Argos Therapeutics
Argos Therapeutics has successfully raised a total of $169.65M across 15 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Argos Therapeutics
Argos Therapeutics has secured backing from 30 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, ABN AMRO and Edelman Financial Engines.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is invested in life science innovations for healthcare transformation.
|
Locked | Locked | Locked | |
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Locked | Locked | Locked | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for Argos Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Argos Therapeutics
Investment portfolio details for Argos Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Argos Therapeutics
Detailed financials for Argos Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Argos Therapeutics Comparisons
Peer comparison for Argos Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Argos Therapeutics
Argos Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Argos Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Argos Therapeutics
Complete news archive for Argos Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Argos Therapeutics
Argos Therapeutics was founded in 1997 and raised its 1st funding round 3 years after it was founded.
Argos Therapeutics is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Argos Therapeutics is a funded company, having raised a total of $169.65M across 15 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Argos Therapeutics is 40.
Annual revenue of Argos Therapeutics is $1.9M as on Dec 31, 2017.
A platform for online Tai Xiu gambling is provided by Argos Therapeutics. Various betting options and promotional offers are featured for users. The service targets players in Vietnam and other regions with a focus on secure transactions. Multiple payment methods including cryptocurrency are supported for user convenience. The platform is designed to cater to a growing community of online gamblers.
Argos Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Argos Therapeutics offers Tai Xiu Online.
Argos Therapeutics has 30 investors. Key investors include SVB, ABN AMRO, Edelman Financial Engines, NIH, and BD.